Boltz PBC Launches with $28M to Democratize AI Platforms for Drug Discovery
jscyc Friday, January 16, 2026
Summary
Boltz PBC, a new biotech company, has launched with $28 million in funding to democratize the use of AI platforms for drug discovery, making these powerful technologies more accessible to a broader range of researchers and organizations.
1
0
Summary
genengnews.com